yf476
Showing 1 - 12 of 12
Barrett's Esophagus Trial in New York, Cambridge (YF476, YF476 )
Completed
- Barrett's Esophagus
- YF476
- YF476 placebo
-
New York, New York
- +1 more
Apr 9, 2021
Chronic Atrophic Gastritis, Hypergastrinaemia, Type I Gastric Carcinoids Trial in Liverpool (YF476)
Completed
- Chronic Atrophic Gastritis
- +2 more
- YF476
-
Liverpool, United KingdomRoyal Liverpool University Hospital
Aug 14, 2019
Chronic Atrophic Gastritis, Hypergastrinemia, Type I Gastric Carcinoids Trial in Trondheim (YF476)
Terminated
- Chronic Atrophic Gastritis
- +2 more
- YF476
-
Trondheim, NorwayInstitutt for kreftforskning og molekylaer medisin
May 14, 2015
Hypergastrinaemia Trial in London (YF476, Rabeprazole)
Completed
- Hypergastrinaemia
- YF476
- Rabeprazole
-
London, United KingdomHammersmith Medicines Research
Oct 2, 2012
Hypergastrinaemia Trial in London (YF476, Placebo)
Completed
- Hypergastrinaemia
- YF476
- Placebo
-
London, United KingdomHammersmith Medicines Research
May 16, 2012
Hypergastrinaemia Trial in London (YF476, Placebo)
Completed
- Hypergastrinaemia
- YF476
- Placebo
-
London, United KingdomHammersmith Medicines Research
May 16, 2012
Reflux Oesophagitis Trial in London (YF476, Omeprazole)
Completed
- Reflux Oesophagitis
- YF476
- Omeprazole
-
London, United KingdomHammersmith Medicines Research
May 14, 2012
Reflux Oesophagitis Trial in London (YF476)
Completed
- Reflux Oesophagitis
- YF476
-
London, United KingdomHammersmith Medicines Research
May 11, 2012
Reflux Oesophagitis Trial in London (YF476, Ranitidine)
Completed
- Reflux Oesophagitis
- YF476
- Ranitidine
-
London, United KingdomHammersmith Medicines Research
Feb 20, 2012
Reflux Oesophagitis Trial in London (YF476)
Completed
- Reflux Oesophagitis
- YF476
-
London, United KingdomHammersmith Medicines Research
Feb 20, 2012